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Abstract
The bacterium Escherichia coli is one of the most popular model systems to study the assembly of membrane proteins of the so-called
helix-bundle class. Here, based on this system, we review and discuss what is currently known about the assembly of these membrane
proteins. In addition, we will briefly review and discuss how E. coli has been used as a vehicle for the overexpression of membrane proteins.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Membrane proteins account for 20–25% of all open
reading frames in sequenced genomes, and they fulfil a
wide range of central functions in the cell, from ion
conductance and nutrient uptake to intra- and intercellular
signalling and cell–cell interactions [1]. The importance of
membrane proteins is probably best illustrated by the fact
that at least 50% of all drug targets are membrane proteins.
Our knowledge of the assembly of this very important class
of proteins is still poor, and functional and structural studies
of membrane proteins have been strongly hampered due to
difficulties in overexpressing them in high yields.
Here we will review what is currently known about the
assembly of membrane proteins in the bacterium Escher-
ichia coli, which is one of the most popular model systems
to study the assembly of membrane proteins of the helix-
bundle class. For the sake of clarity, in this review we will
only deal with the assembly of membrane proteins of the
helix-bundle class (i.e., inner membrane proteins, which
we hereafter will refer to as membrane proteins) and not
the h-barrel outer membrane proteins. Finally, we will
briefly review and discuss how E. coli has been used as
a vehicle for the overexpression of membrane proteins.
2. Assembly of membrane proteins in E. coli
2.1. Translocation of proteins across the inner membrane
Before we give an overview of what is known about the
assembly of membrane proteins in E. coli, we will briefly
discuss the translocation of secretory proteins across the
inner membrane. This is necessary for a good understand-
ing of the assembly of membrane proteins. Almost all
components of the machinery involved in the translocation
of secretory proteins across the inner membrane of E. coli,
the so-called Sec machinery, were initially identified in
genetic screens [2]. Biochemical studies have further
characterized the Sec machinery [3–5]. Secretory proteins
are kept in a translocation competent state (i.e., noncom-
pletely folded state) by the chaperone SecB. The SecB–
secretory protein complex is targeted at a late stage during
translation or after translation to the inner membrane,
where the secretory protein is delivered at the Sec trans-
locase. The Sec translocase mediates the translocation of
secretory proteins across the inner membrane. The core of
the Sec translocase consists of the integral membrane
proteins SecY, SecE, and SecG, and the peripheral subunit
SecA, which exists as a dimer. SecYEG forms together
with SecA a molecular machine that drives the stepwise
translocation of secretory proteins across the inner mem-
brane driven by the proton-motive force and ATP hydrol-
ysis.
How the Sec components form a functional Sec translo-
case is matter of a vivid debate. Electron-microscopic
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examination of purified translocase indicated that under
translocation conditions, four SecYEG heterotrimers assem-
ble, catalyzed by dimeric SecA, into one large protein
complex, forming a protein-conducting channel [6]. In
contrast, a monomeric translocon was proposed based on
co-immunoprecipitation and cross-linking experiments [7].
Based on combined 2D-crystallography, analytical ultracen-
trifugation, and native gel electrophoresis experiments, it
was proposed that the active Sec translocase is comprised of
a SecYEG dimer in the absence of SecA [8–10].
SecD, SecF, and YajC are additional nonessential trans-
locase subunits that facilitate the translocation reaction.
They form a subcomplex that under certain conditions can
be co-purified with the SecYEG complex. SecDFYajC has
been implicated in diverse processes like SecA functioning,
release of translocated proteins, and also the maintenance of
the proton-motive force across the inner membrane [3].
However, a recent study has questioned the role of SecD-
FYajC in maintaining the proton-motive force [11].
The assembly of membrane proteins in E. coli was
initially studied in Sec mutant strains selected for protein
secretion defects, and with the SecA inhibitor sodium azide.
These studies did not point to a role of the Sec machinery in
the assembly of membrane proteins, except for large
domains of membrane proteins that have to cross the inner
membrane [12,13]. However, it should be stressed that the
strains that were used had been selected for secretion defects
rather than membrane protein assembly defects. Further-
more, sodium azide only partially inhibits the activity of the
Sec translocase subunit SecA.
In vivo studies using improved conditional Sec strains
and in vitro studies using cross-linking and reconstitution
techniques have pointed to a more prominent and general
role for the Sec translocase in membrane protein assembly.
2.2. The SRP targeting pathway
In E. coli, most membrane proteins are targeted to the
inner membrane via the S(ignal)R(ecognition)P(article) tar-
geting pathway [14,15]. The SRP targeting pathway in E.
coli is homologous to the SRP targeting pathway that targets
both secretory and membrane proteins to the endoplasmic
reticulum (ER) membrane in eukaryotes [16,17]. The
eukaryotic SRP binds during biosynthesis to the N-terminal
signal sequence of secretory and membrane proteins when it
is just exposed outside the ribosome. Further translation is
inhibited until the SRP contacts its receptor at the ER
membrane, and subsequently dissociates from the nascent
chain. The core of the eukaryotic SRP consists of a GTP-
binding protein, the 54-kDa subunit (SRP54), and the 7SL
RNA. They participate in a larger complex that binds to the
signal sequence via SRP54. At the ER membrane, the SRP
makes contact with its receptor subunit S(ignal recognition
particle)R(eceptor)a, which is tethered to the membrane via
the integral membrane subunit SRh. Both SRa and SRh are
GTP-binding proteins.
In E. coli, Ffh (Fifty-four homolog), 4.5S RNA, and FtsY
are homologous to the eukaryotic SRP54, 7SL RNA, and
SRa, respectively. Depletion of Ffh, 4.5S RNA and FtsY
does not affect the translocation of most secretory proteins
across the inner membrane, which does not mean that the
SRP pathway cannot target secretory proteins to the inner
membrane [18,19]. The preferred substrates for SRP-medi-
ated targeting appear to be membrane proteins [15,20]. Bio-
genesis of most (of only a limited test set of) membrane
proteins is strongly hampered upon the depletion of Ffh, 4.5S
RNA, and FtsY, which might explain the essential nature of
these components. Recently, genetic screens were success-
fully employed where Ffh, 4.5S RNA, and FtsY were
identified as factors that are involved in the targeting of
membrane proteins to the inner membrane [21,22]. Finally,
cross-linking studies have demonstrated that the E. coli SRP
preferentially binds to particularly hydrophobic targeting
signals present in the N-terminus of nascent membrane
proteins [23,24].
In contrast to its eukaryotic counterpart, FtsY is located
both in the cytoplasm and at the inner membrane [25] and can
already interact with ribosome/nascent chain/SRP complexes
in the cytosol. Consequently, FtsY might play a direct role in
the targeting of these complexes. The mechanism and regu-
lation of membrane association of FtsY is still enigmatic but
appears complex, involving both protein and direct lipid
contacts [14,26–28]. Upon interaction with membrane lipids,
the GTPase activity of FtsY (and probably also of the bound
SRP) is stimulated, which might result in the dissociation of
the targeting complex. The released nascent chain is then
transferred to the insertion site in a process that is poorly
defined in both prokaryotic and eukaryotic cells.
In vitro studies using artificially truncated nascent chains
suggested that the E. coli SRP can mediate co-translational
targeting, but the in vivo relevance of these observations is
still uncertain [29]. To enable co-translational targeting, the
mammalian and yeast SRPs slow down translation upon
interaction with the nascent chain. However, the SRP sub-
units responsible for this feature have no homologs in E. coli.
Therefore, despite a recent claim that the E. coli SRP can
arrest translation [30], it is still generally assumed that it
cannot. A posttranslational role of the E. coli SRP cannot be
excluded, and has a precedent in chloroplast SRP that
interacts posttranslationally with thylakoid membrane pro-
teins that are imported from the cytosol. Notably, the E. coli
SRP is essential for the targeting of a model membrane
protein with only one transmembrane segment (signal anchor
sequence) that is located at the very C-terminus of the protein,
suggesting a posttranslational mode of targeting [31,32].
2.3. Are there alternative membrane protein targeting
pathways?
In E. coli cells completely depleted for SRP, assembly of
SRP-dependent membrane proteins is not completely
blocked [33,34]. How can these membrane proteins be
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assembled in the absence of a functional SRP targeting
pathway? Possible alternative mechanisms to explain this
include mRNA-, ribosome-, and chaperone-mediated target-
ing.
It has been shown that the large subunit of the mamma-
lian ribosome can remain associated with the ER membrane
after termination of translation [35–37]. This large subunit
can, if it is programmed with mRNA encoding secretory or
membrane proteins, recruit a small subunit and subsequently
mediate the insertion and translocation of natural SRP
substrates in an SRP-independent fashion. This would imply
mRNA targeting, which seems to be widespread in eukar-
yotes [38,39]. Interestingly, recent studies strongly suggest
that mRNA targeting also occurs in bacteria [40,41].
A role for FtsY in the general targeting of ribosomes to
the E. coli inner membrane has also been postulated, but the
fate and function of these targeted ribosomes awaits further
analysis [27,42]. In addition, the affinity of ribosomes for
the translocase appears to be a conserved feature that also
applies to E. coli [43]. This affinity, together with an
exposed targeting signal, might be sufficient to target a
subpopulation of membrane proteins to the translocase in
the absence of SRP.
Finally, it has been suggested, based on an in vitro study,
that in E. coli, the chaperone GroEL can mediate the
posttranslational targeting of the membrane protein lactose
permease [44]. Interestingly, evidence has been presented
that GroEL can make a link with the inner membrane by
interacting with the Sec translocase component SecA [45].
If GroEL indeed would play a role in membrane protein
targeting, one would expect that upon SRP-depletion, the
expression of GroEL would be upregulated. However, this
is not the case [46].
2.4. Membrane insertion
As mentioned before, until recently, it was generally
assumed that in E. coli, the Sec translocase was only
involved in the translocation of large periplasmic domains
of membrane proteins across the inner membrane. However,
detailed biochemical analysis of the insertion of membrane
proteins into the ER membrane in eukaryotes initiated a
reevaluation of the role of the Sec translocase in the
assembly of membrane proteins in E. coli.
At the ER membrane, the SRP is released from the
arrested nascent polypeptide in a GTP-dependent process
that requires both subunits of the SR [47] and the trans-
locon, the Sec61 complex [48]. The nascent chain, freed of
SRP, enters the translocon that is sealed to the ribosome to
form one continuous channel to allow a tightly coupled
translation/translocation reaction. A cryo-electron micro-
scopy study has provided us with a snapshot of this process
[49].
The core of the Sec61 complex consists of the Sec61a,
Sec61h, and Sec61g components. The Sec61a and Sec61g
components are homologous to the bacterial Sec translocase
components SecY and SecE, respectively [16]. There is no
homologue of the Sec translocase component SecA in the
Sec61 translocon, which may be related to different mech-
anisms to energize insertion and translocation. On the other
hand, the ER translocon contains an accessory component
TRAM, which has no structural homologue in E. coli.
Biochemical and electron microscopy studies indicate that
purified Sec61 heterotrimers form oligomers and each
oligomer contains three to four Sec61 heterotrimers that
constitute the functional translocation channel, which is
approximately 40–60 A˚ wide during translocation [50,51].
The aforementioned cryo-electron microscopy study points
to a Sec translocon consisting of three Sec61 heterotrimers,
but to a translocation channel that is considerably less wide
than 40–60 A˚ [49]. This may reflect the dynamic nature of
the translocon [52].
Oligomer formation is stimulated by the association of
the Sec61 heterotrimer subunit Sec61a with ribosomes
[48,50], which is mediated by the 28S rRNA of the large
ribosomal subunit [43]. During the early stages of nascent
chain insertion, the Sec61 channel is blocked at the lumenal
side by Bi(nding)P(rotein), which maintains the permeabil-
ity barrier at rest [53]. In addition, it has been suggested that
BiP functions as a molecular ratchet, rather than a ‘pulling
force’, which assists polypeptide chains to cross the mem-
brane [54]. It has been suggested that transmembrane
signalling may play a role in mediating a concerted action
of factors that are involved in the membrane protein
assembly process on either side of the membrane [55].
Hydrophilic polypeptides are translocated across the
membrane. They can be glycosylated and partially folded
at the lumenal side of the membrane while still attached to
the ribosome at the cytosolic side. Hydrophobic transmem-
brane segments get trapped in the translocon, and at some
stage move out into the lipid bilayer [56]. The exact
mechanism by which this is achieved is not clear, but
appears to differ depending on the nature, number, and
orientation of the transmembrane segments (a discussion on
this area of the assembly of membrane proteins can be found
in Ref. [52]).
Genetic studies hinted first at an important role of the E.
coli Sec translocase components SecA, SecE, and SecY in
the insertion of membrane proteins [57–59]. In vitro cross-
linking studies indicate that membrane proteins that are
targeted by the SRP/FtsY pathway insert at the SecAYEG
translocase that is also used for the translocation of sub-
strates of the SecB targeting route. Nascent model mem-
brane proteins of different topology and complexity were
released from the SRP after docking of FtsY at the mem-
brane, and inserted into the membrane close to SecY, and,
depending on the model protein, to SecA [60–65]. The
mechanism of transfer of the nascent chain from the SRP to
the translocase is still enigmatic (like in eukaryotic systems)
but could involve yet unidentified direct interactions of FtsY
and the SRP with the translocase. Interestingly, the Bacillus
subtilis Ffh appears to have affinity for SecA in an in vitro
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binding study [66]. Alternatively, the affinity of ribosomes
for the translocase might contribute to the transfer reaction
[43]. It is also possible that the membrane surrounding of
the translocase is enriched in acidic phospholipids that bind
FtsY. In this respect, it is noteworthy that SecA, like FtsY,
also preferentially binds to acidic phospholipids. In E. coli,
in contrast to eukaryotes, the presence of the Sec translocase
is not strictly required for the release of the nascent chain
from the SRP [67]. Photo cross-linking studies using the
model membrane protein FtsQ, which has one transmem-
brane segment and its N-terminus in the cytoplasm and its
C-terminus in the periplasm, have shown that the earliest
interactions of the transmembrane segment with the mem-
brane involve both SecY and lipids [63]. These interactions
are detected when the transmembrane segment is not even
fully exposed outside the ribosome, reminiscent of the
situation in the ER described above, suggesting a conserved
mechanism of insertion. It remains to be demonstrated
whether the insertion takes place in the interior of the
translocation channel (to which the lipids would have
access) or between the interface of the translocase and the
lipid surroundings [52]. The hydrophilic regions of mem-
brane targeted nascent FtsQ were shown to have extensive
contact with both SecA and SecY. In contrast, mannitol
permease (MtlA), which is a polytopic membrane protein,
was found to contact only SecY in a similar approach, which
might be related to the presence of a large periplasmic loop
in FtsQ and not in MtlA, that does not require SecA for its
assembly in vivo [62,68].
It has been suggested (see also above) that SecA triggers
the oligomerization of SecYEG trimers into a functional
translocation unit [6]. For SecA-independent membrane
proteins like MtlA, bacterial ribosomes, rather than SecA,
might be the trigger for the oligomerization of SecYEG
trimers. Furthermore, the physical link between the ribo-
some and the translocase may serve as a handle to push the
nascent chain into the translocon obviating the need for
SecA to energize membrane protein insertion [43,49].
Notably, SecA is not required for the initial membrane
insertion of FtsQ [67], whereas it is essential for the
complete assembly of the protein in vivo [63]. It is unclear
if SecA would not always be available at the translocation
site, when and how the need for SecA recruitment at the
translocation site is sensed, when it is only necessary at a
later stage in membrane protein assembly [64,69].
When translocation intermediates of secretory proteins
are stuck in the inner membrane, they can be photo cross-
linked to SecA and SecY [70]. Again, these interaction
studies show that a similar or identical channel is used for
both secretory and membrane proteins. The translocase
seems to scan polypeptide chains for hydrophobic domains,
and if amino acid stretches are sufficiently hydrophobic,
translocation stops [71].
How do transmembrane segments move from the trans-
locase into the lipid bilayer? In vitro crosslinking and in
vivo depletion studies have identified a novel component
that might be involved in this process: YidC [29,61,72]. At a
nascent chain length of approximately 100 amino acids, the
signal anchor sequence of two nascent model membrane
proteins of different topology, FtsQ and Lep, were specif-
ically photo cross-linked to YidC and to lipids while their
hydrophilic regions were still close to SecA and SecY,
suggesting that YidC is close to the translocase during
membrane protein insertion. Similar observations were
made for the multispanning membrane protein MtlA. The
studies with MtlA indicated that YidC can simultaneously
accommodate more than one transmembrane segment at the
protein–lipid interface [65].
YidC could be co-purified with the Sec translocase and
overexpression of translocase components positively affected
YidC expression, suggesting a functional relationship [61].
YidC seems to interact with the SecDFYajC complex [73]. At
least, the sequential interaction of the transmembrane seg-
ment of nascent FtsQ with SecYand YidC suggests that YidC
acts after SecY has received the transmembrane segment in
the membrane [61,63]. A similar order of interactions was
detected in the mammalian ER with TRAM in the role of
YidC. It remains to be established whether YidC and TRAM,
which show no obvious similarity in primary sequence, are
homologous in function [74]. Recently, besides a role for
YidC in lipid partitioning of transmembrane segments, it has
been suggested that YidC also plays a role in the reception of
transmembrane segments at the membrane [75].
YidC is not only involved in the assembly of Sec-
dependent membrane proteins. Depletion of YidC in a
conditional strain not only affected the biogenesis of Sec-
dependent membrane proteins but also of Sec-independent
proteins like the small bacteriophage M13 procoat and Pf3
coat proteins [72,76,77]. It seems possible that YidC some-
how facilitates lipid partitioning of the transmembrane seg-
ments of simple Sec-independent proteins without actually
forming a translocation channel.
Interestingly, in the E. coli cell, most YidC molecules
seem to be localized at the poles [64]. The key-role of YidC
in membrane protein assembly in E. coli makes it tempting
to speculate that in E. coli membrane proteins are synthe-
sized at the poles of the cell and subsequently sorted to their
final destination.
2.5. Assembly and folding of membrane proteins
Like in the ER, it is unclear whether transmembrane
segments of polytopic membrane proteins that insert into
the E. coli translocase move one by one into the lipid bilayer
or en bloc after assembly and partial folding in the translocase
[52]. Whatever the mechanism, the lipid bilayer is the final
destination of a membrane protein. Evidence is accumulating
that lipids have a more specific role than merely providing a
solvent for membrane proteins [78,79]. Phosphatidylethanol-
amine appears to assist the folding of the membrane protein
lactose permease. In this respect, lipids can be considered to
function as molecular chaperones for membrane proteins.
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Membrane proteins also contain cytoplasmic and periplasmic
loops that might have to be correctly folded during or after
synthesis. The role of chaperones in the folding of these loops
has hardly been studied (see Ref. [80] for an example).
Besides the hydrophobic transmembrane segments, mem-
brane proteins contain more information that determines
their final structure and topology in the membrane. The
distribution of positively charged amino acid residues is a
major determinant of the transmembrane topology of mem-
brane proteins [81]. The ‘positive inside rule’ states that
regions of membrane proteins facing the cytoplasm are
generally enriched in arginyl and lysyl residues, whereas
translocated regions are largely devoid of these residues. It is
still not clear how positively charged amino acid residues
determine the topology of membrane proteins [82].
In systems other than E. coli, it has been shown that the
binding of cofactors is sometimes needed for a membrane
protein to reach its fully folded state. The binding of retinal
to bacteriorhodopsin and of chlorophylls to the light-har-
vesting complex II are probably the best examples [83,84].
When membrane proteins are part of a complex, complex
formation may also be needed for membrane proteins to
reach their fully folded state.
2.6. Alternative membrane protein assembly pathways
Our knowledge of the biogenesis of membrane proteins
in E. coli is based on monitoring the analysis of only a very
limited number of (model) membrane proteins. It is very
well possible that this has biased our ideas on membrane
protein biogenesis. Evidence has emerged that the SRP/Sec
translocase pathway is not the only membrane protein
targeting/insertion pathway in E. coli. The bacteriophage
M13 procoat and Pf3 coat proteins are the best known
examples of membrane proteins that require neither the SRP
targeting pathway nor any of the Sec components for their
biogenesis [57,72,85].
In vivo depletion studies have provided evidence for a
third membrane targeting/insertion pathway in E. coli: the
SRP/YidC pathway [32]. It seems that in E. coli, the SRP
targeting pathway can deliver membrane proteins directly to
YidC, without involvement of any of the Sec components.
In chloroplasts, which have a prokaryotic ancestor, a similar
pathway is operational [86]. The chloroplast SRP can
deliver membrane proteins without involvement of any of
the CpSec components, to the thylakoidal membrane protein
Albino3, which is the chloroplast homolog of YidC [87].
In E. coli, besides the Sec protein secretion pathway,
another protein secretion pathway is operational, the
T(win)A(rginine)T(ranslocation) pathway [88]. Pre-proteins
transported by the TAT pathway usually bind redox cofac-
tors and fold or even oligomerize before translocation across
the membrane, whereas the Sec machinery can only accom-
modate noncompletely folded polypeptide chains. TAT
substrates are characterized by an N-terminal signal peptide
that contains a consensus ‘‘twin arginine’’ (RR) motif. So
far, no clear example of a bacterial membrane protein
targeted/inserted through the TAT pathway has been found.
However, in chloroplasts, where a similar TAT pathway is
operational, insertion of at least two thylakoidal membrane
proteins that do not contain a twin arginine motif is
mediated by the TAT pathway [89,90]. Thus, it cannot be
ruled out that in E. coli, the TAT pathway assists the
biogenesis of certain membrane proteins. In addition, it
should be mentioned that, in principle, it is still possible
that there are membrane proteins that can insert spontane-
ously (i.e., without the aid of protein factors) into the inner
membrane (see e.g., Ref. [91]).
2.7. Concluding remarks
It is very likely that in E. coli, besides the SRP targeting
pathway, there are alternative targeting mechanisms for
membrane proteins. It is not known if one and the same
Sec translocase is involved in the biogenesis of all Sec-
dependent membrane proteins, or that there are different
‘specialized’ Sec translocases. It is also not known if Sec
translocases are ‘ready to use’, or that Sec translocases are
assembled during the membrane protein insertion process,
depending on the needs of the membrane protein that is to
be inserted into the inner membrane. It has been shown that
secretory and membrane proteins engage different domains/
components of the Sec translocase [59,92]. This probably
explains why the biogenesis of membrane proteins, except
the ones with large periplasmic domains, is not affected in
E. coli mutant strains that are selected for protein secretion
defects.
It appears that in E. coli, at least three different mem-
brane protein targeting and insertion pathways exist: the
SRP/Sec translocase pathway, the YidC pathway, and the
SRP/YidC pathway [32]. The reason for and the relevance
of these different membrane protein targeting and insertion
pathways remain obscure.
So far, studies on the biogenesis of membrane proteins in
E. coli have mainly focussed on identifying the components
involved, and efforts have been made to reconstruct target-
ing and assembly pathways. It is very likely that not all
components involved in membrane protein biogenesis have
been identified yet, making it also possible that there are still
unidentified membrane protein assembly pathways in E.
coli.
Many important topics concerning the biogenesis of
membrane proteins in E. coli, such as the role of the
proton-motive force, lipids, the quality control of membrane
protein biogenesis, the location of membrane protein bio-
genesis in the cell, cofactor binding, and the formation of
membrane protein complexes have barely been touched yet.
In a ‘normal’ E. coli cell, there are around 20.000–30.000
ribosomes, 40 SRP, 10.000 FtsY, 500 SecY/E/G, 2000
SecA, 30–40 SecD/F, and 2500 YidC molecules. At
present, with our current knowledge of the assembly of
membrane proteins in E. coli, we can only speculate as to
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the reasons behind the differences in abundance of these
components.
3. Membrane protein overexpression in E. coli
The overexpression of membrane proteins is an impor-
tant bottleneck in studies of membrane protein function and
structure (see, e.g., the Structural genomics supplement of
Nature Structural Biology, November 2000). E. coli is one
of the most widely used vehicles to overexpress both
prokaryotic and eukaryotic (membrane) proteins since E.
coli is very well accessible and easy to handle. Here we will
only deal with the overexpression of membrane proteins.
For more general information on the overexpression of
proteins in E. coli, we refer to other review articles (see,
e.g., Refs. [93,94]).
Is there a link between the overexpression and assembly
of membrane proteins? Yes, since the overexpression of
membrane proteins in a membrane is strongly favoured to
the overexpression of membrane proteins in inclusion
bodies. The reason being that it is relatively easy to isolate
membrane proteins from a membrane, and usually very
complicated to isolate them from inclusion bodies. There
are only very few examples of membrane proteins that have
successfully been isolated from inclusion bodies (see, e.g.,
Refs. [95,96]). It should be kept in mind that the over-
expression of a membrane protein in a membrane does not
necessarily mean that the membrane protein is also func-
tional. The lipid composition of the membrane, cofactor
binding, and other subunits when the membrane protein is
part of a complex are among the factors that can determine
if a membrane protein is functional or not.
At present, it is impossible to predict whether a mem-
brane protein can be overexpressed. If the membrane protein
can be overexpressed, it is not possible to predict if it will be
overexpressed in inclusion bodies or in the membrane. This
means that membrane protein overexpression is basically
still a matter of ‘trial and error’. To facilitate monitoring
membrane protein overexpression in E. coli under many
different conditions (e.g., under different culture conditions
and in different strains), we have developed a green fluo-
rescent protein (GFP) based membrane protein screen
[97,98]. In short, GFP is fused to the C-terminus of the
membrane protein in question. If the overexpressed GFP
fusion ends up as inclusion bodies, GFP does not fold and is
therefore not fluorescent. However, if the GFP fusion is
expressed in the cytoplasmic membrane, GFP folds properly
and is fluorescent. This screen speeds up the identification
of membrane proteins that can be overexpressed well in E.
coli, but does not help to improve the overexpression of
membrane proteins that cannot or only poorly be (over)ex-
pressed. Hopefully, by studying the expression of a large
number of membrane proteins, it may be possible to find
some correlation between membrane proteins that ‘express
well’ to those that ‘express poorly’. It should be mentioned
that the expression of membrane proteins does not seem to
be affected by the GFP moiety [97], and that membrane
proteins can easily be recovered from membrane protein
GFP fusions [97]. Furthermore, it has been shown that the
GFP moiety does not necessarily interfere with the function-
ing of a membrane protein (see, e.g., Refs. [64,99]).
Recently, E. coli mutant strains with improved (mem-
brane) protein overexpression characteristics were isolated
[100]. The way the strains were isolated indicates that
they have accumulated multiple mutations, which have
not yet been characterized. For the overexpression of
membrane proteins, one very interesting observation has
been made; upon the overexpression of a membrane
protein, the intracellular membranes of one of these
mutant strains can proliferate [101]. It is clear that
membranes do not have an unlimited capacity to harbour
membrane proteins and the proliferation of membranes
could therefore explain the improved membrane protein
overexpression yields.
The physiological consequences of the overexpression of
membrane proteins in E. coli have hardly been studied,
though they may give important clues as to why it is so
difficult to overexpress membrane proteins. It has been
shown that upon overexpression of membrane proteins, free
SRP is titrated out [24]. Furthermore, in a recent study, G-
protein-coupled receptors were successfully overexpressed
in high quantities in a membrane system with an enormous
membrane protein assembly capacity [102]. Together, these
studies raise the question if the co-overexpression of factors
involved in the assembly of membrane proteins would
improve membrane protein overexpression yields. However,
is our current knowledge of the assembly of membrane
proteins sufficient to pursue co-overexpression strategies? Is
it technically possible to co-overexpress the many factors
that are involved in the assembly of membrane proteins in a
concerted way? How does the cell react to the co-over-
expression of factors involved in the assembly of membrane
proteins? It is also very well conceivable that there are
heterologous membrane proteins that are not the perfect
substrates for the E. coli membrane protein assembly
machinery. Tailoring of components for heterologous mem-
brane protein overexpression is an intriguing but maybe not
very realistic option.
Degradation of membrane proteins may also be an
important factor that interferes with the overexpression of
membrane proteins. Surprisingly, only very little is known
about the degradation of membrane proteins in E. coli.
However, there is one beautiful example of how a protease
can interfere with the overexpression of a membrane protein
in E. coli. When the Sec translocase component SecY is
overexpressed, it is rapidly degraded by the FtsH protease
[103]. However, SecY can be stably overexpressed when it
is co-overexpressed with the Sec translocase component
SecE, with which it forms a complex. A SecY derivative
with a periplasmic PhoA moiety can be stably overex-
pressed; FtsH cannot pull this fusion out of the membrane
D. Drew et al. / Biochimica et Biophysica Acta 1610 (2003) 3–108
[104]. Thus, it is possible to stabilise overexpressed mem-
brane proteins.
Taken together, membrane protein research would prob-
ably benefit a lot if the overexpression of membrane proteins
would be considered as a science rather than an obligatory
first step in studies of membrane proteins.
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